Stocks and Investing Stocks and Investing
Thu, February 29, 2024
Wed, February 28, 2024

Francois Brisebois Reiterated (TARS) at Buy with Increased Target to $59 on, Feb 28th, 2024


Published on 2024-10-28 09:17:54 - WOPRAI, Francois Brisebois
  Print publication without navigation


Francois Brisebois of Oppenheimer, Reiterated "Tarsus Pharmaceuticals, Inc." (TARS) at Buy with Increased Target from $55 to $59 on, Feb 28th, 2024.

Francois has made no other calls on TARS in the last 4 months.



There is 1 other peer that has a rating on TARS. Out of the 1 peers that are also analyzing TARS, all agrees with Francois's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $19 on, Monday, November 20th, 2023
Contributing Sources